Overview

A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers

Status:
Completed
Trial end date:
2019-12-20
Target enrollment:
Participant gender:
Summary
This study explores the safety, pharmacodynamics and pharmacokinetics of THN201 a combination of donepezil and mefloquine to improve cognitive function in healthy male volunteers after impairment by a scopolamine challenge.
Phase:
Phase 1
Details
Lead Sponsor:
Theranexus
Treatments:
Donepezil
Mefloquine